Jun Chen, Zhiwei Zheng, Mingqi Li, Chengkun Cao, Xuli Zhou, Bozhen Wang, Xin Gan, Zhicheng Huang, Yugang Liu, Wenting Huang, Fei Liang, Keyang Chen, Yeli Zhao, Xue Wang, Jianzhang Wu, Li Lin
Curcumin is identified that it has the potential to treat Parkinson's disease (PD), but its instability limits its further application in clinic. The mono-carbonyl analogs of curcumin (MACs) with diketene structure can effectively improve its stability, but it is highly toxic. In the present study, a less cytotoxic and more stable monoketene MACs skeleton S2 was obtained, and a series of monoketene MACs were synthesized by combining 4-hydroxy-3‑methoxy groups of curcumin. In the 6-OHDA-induced PD's model in-vitro, some compounds exhibited significant neurotherapeutic effect...
April 17, 2023: Bioorganic Chemistry